Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-23-000179 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
211.83% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 100th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.55% · OPTIONAL · VALID
Operating cash generation 42th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
37.13% · OPTIONAL · VALID
Share-count growth 13th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.shares_outstanding
-3.12% · CORE · VALID
Revenue growth 33th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
-1.07% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
55.56% · OPTIONAL · VALID
Gross margin 16th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
63.76% · CORE · VALID
Operating margin 63th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
30.21% · CORE · VALID
R&D intensity 11th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.77% · OPTIONAL · VALID
SBC intensity 68th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.70% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 199.73%
Current 211.83%
Delta 12.10% Capex Intensity Increased
Previous 8.71%
Current 10.55%
Delta 1.84% Cash Generation Increased
Previous 33.15%
Current 37.13%
Delta 3.99% Dilution Increased
Previous -3.54%
Current -3.12%
Delta 0.42% Growth Decreased
Previous 9.79%
Current -1.07%
Delta -10.86% Inventory Pressure Increased
Previous 50.51%
Current 55.56%
Delta 5.05% Margin Decreased
Previous 65.72%
Current 63.76%
Delta -1.96% Profitability Decreased
Previous 34.58%
Current 30.21%
Delta -4.37% R And D Intensity Increased
Previous 12.74%
Current 13.77%
Delta 1.03% Sbc Intensity Increased
Previous 2.12%
Current 2.70%
Delta 0.58% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.